amiodarone has been researched along with Cardiotoxicity in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phospholipidosis (PLD) is characterized by an intracellular accumulation of phospholipids in lysosomes and concurrent development of concentric lamellar bodies." | 1.42 | Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment. ( Bocchini, N; Cristofori, P; Crivellente, F; Dacasto, M; Faustinelli, I; Ferraresso, S; Giantin, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bocchini, N | 1 |
| Giantin, M | 1 |
| Crivellente, F | 1 |
| Ferraresso, S | 1 |
| Faustinelli, I | 1 |
| Dacasto, M | 1 |
| Cristofori, P | 1 |
1 other study available for amiodarone and Cardiotoxicity
| Article | Year |
|---|---|
Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
Topics: Amiodarone; Animals; Biomarkers; Cardiotoxicity; Drug Evaluation, Preclinical; Gene Ontology; Leukoc | 2015 |